Detection of fumarate–glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

(2012) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells

(2011) Kamran Ghoreschi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients

(2010) Martin Rostami-Yazdi et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Detection of Metabolites of Fumaric Acid Esters in Human Urine: Implications for Their Mode of Action

(2008) Martin Rostami-Yazdi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

(2008) Ludwig Kappos et al.   LANCET